| MWF/FubRkb |
fetal body weight |
control condition |
Schulte L, etal., J Hypertens. 2012 Oct;30(10):2031-8. doi: 10.1097/HJH.0b013e328356a60a. |
body mass |
not specified |
-6.0 days
| 11 |
0.26 |
g |
0.01 |
0.03 |
body weighing method |
0.0 |
|
109501 |
3145 |
| MWF/FubRkb |
body weight |
control condition |
Rothermund L, etal., J Hypertens. 2006 Sep 24(9). |
body mass |
not specified |
100.0 days
| |
334.0 |
g |
6.0 |
|
body weighing method |
0.0 |
|
108083 |
3115 |
| MWF/FubRkb |
body weight |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
body mass |
male |
30.0 days
| 5 |
98.42 |
g |
0.88 |
1.96 |
body weighing method |
0.0 |
|
109703 |
3152 |
| MWF/FubRkb |
body weight |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
body mass |
male |
168.0 days
| 18 |
363.9 |
g |
11.3 |
47.94 |
body weighing method |
0.0 |
|
108920 |
3133 |
| MWF/FubRkb |
body weight |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
body mass |
female |
168.0 days
| 18 |
207.2 |
g |
1.2 |
5.09 |
body weighing method |
0.0 |
|
12760 |
309 |
| MWF/FubRkb |
fetal body weight |
control condition |
Schulte L, etal., J Hypertens. 2012 Oct;30(10):2031-8. doi: 10.1097/HJH.0b013e328356a60a. |
body mass |
not specified |
-6.0 days
| 11 |
0.26 |
g |
0.01 |
0.03 |
body weighing method |
0.0 |
|
109508 |
3145 |
| MWF/FubRkb |
body weight |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
body mass |
female |
44.0 days
| 5 |
145.2 |
g |
2.44 |
5.45 |
body weighing method |
0.0 |
|
109706 |
3152 |
| MWF/FubRkb |
body weight |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
body mass |
female |
58.0 days
| 5 |
164.3 |
g |
5.56 |
12.44 |
body weighing method |
0.0 |
|
109708 |
3152 |
| MWF/FubRkb |
fetal body weight |
control condition |
Rothermund L, etal., J Hypertens. 2006 Sep 24(9). |
body mass |
not specified |
-6.0 days
| |
0.24 |
g |
0.0 |
|
body weighing method |
0.0 |
|
108067 |
3115 |
| MWF/FubRkb |
fetal body weight |
control condition |
Rothermund L, etal., J Hypertens. 2006 Sep 24(9). |
body mass |
not specified |
-4.0 days
| |
0.62 |
g |
0.01 |
|
body weighing method |
0.0 |
|
108068 |
3115 |
| MWF/FubRkb |
body weight |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
body mass |
not specified |
168.0 days
| 18 |
363.9 |
g |
11.3 |
47.94 |
body weighing method |
0.0 |
|
65360 |
117 |
| MWF/FubRkb |
body weight |
vehicle control condition (for 28 days) |
Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. |
body mass |
male |
112.0 days
| 10 |
362.8 |
g |
12.8 |
40.48 |
body weighing method |
0.0 |
|
109389 |
3140 |
| MWF/FubRkb |
neonatal body weight |
control condition |
Rothermund L, etal., J Hypertens. 2006 Sep 24(9). |
body mass |
not specified |
7.0 days
| |
13.4 |
g |
0.2 |
|
body weighing method |
0.0 |
|
108079 |
3115 |
| MWF/FubRkb |
body weight |
control condition |
Schulz A, etal., Physiol Genomics. 2010 Jun. |
body mass |
male |
84.0 days
| |
279.3 |
g |
5.5 |
|
body weighing method |
0.0 |
|
109039 |
3116 |
| MWF/FubRkb |
body weight |
control condition |
Schulz A, et al., J Am Soc Nephrol 2002 Nov;13(11):2706-14. |
body mass |
not specified |
126.0 days
| 8 |
333.1 |
g |
6.93 |
19.6 |
body weighing method |
0.0 |
|
67593 |
769 |
| MWF/FubRkb |
body weight |
finerenone (10 mg/kg/d) (for 28 days) |
Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. |
body mass |
male |
112.0 days
| 10 |
350.3 |
g |
9.0 |
28.46 |
body weighing method |
0.0 |
|
109390 |
3140 |
| MWF/FubRkb |
body weight |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
body mass |
female |
30.0 days
| 5 |
80.61 |
g |
3.72 |
8.31 |
body weighing method |
0.0 |
|
109704 |
3152 |
| MWF/FubRkb |
body weight |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
body mass |
male |
58.0 days
| 5 |
241.28 |
g |
4.47 |
10.0 |
body weighing method |
0.0 |
|
109707 |
3152 |
| MWF/FubRkb |
body weight |
controlled NG-nitroarginine methyl ester content drinking water (5 mg/kg/d) (for 42 days) |
Schulz A, etal., Physiol Genomics. 2010 Jun. |
body mass |
male |
84.0 days
| |
270.7 |
g |
4.9 |
|
body weighing method |
0.0 |
|
109040 |
3116 |
| MWF/FubRkb |
neonatal body weight |
control condition |
Rothermund L, etal., J Hypertens. 2006 Sep 24(9). |
body mass |
not specified |
1.0 days
| |
6.12 |
g |
0.8 |
|
body weighing method |
0.0 |
|
108077 |
3115 |
| MWF/FubRkb |
neonatal body weight |
control condition |
Rothermund L, etal., J Hypertens. 2006 Sep 24(9). |
body mass |
not specified |
12.0 days
| |
21.6 |
g |
0.6 |
|
body weighing method |
0.0 |
|
108081 |
3115 |
| MWF/FubRkb |
body weight |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
body mass |
male |
44.0 days
| 5 |
203.06 |
g |
10.29 |
23.0 |
body weighing method |
0.0 |
|
109705 |
3152 |
| MWF/FubRkb |
fetal body weight |
control condition |
Rothermund L, etal., J Hypertens. 2006 Sep 24(9). |
body mass |
not specified |
-2.0 days
| |
2.03 |
g |
0.05 |
|
body weighing method |
0.0 |
|
108069 |
3115 |
| MWF/FubRkb |
body weight |
control condition |
Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384. |
body mass |
male |
84.0 days
| 10 |
302.6 |
g |
4.3 |
13.6 |
body weighing method |
0.0 |
|
109274 |
3141 |
| MWF/FubRkb |
body weight |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
body mass |
female |
168.0 days
| 18 |
207.2 |
g |
1.2 |
5.09 |
body weighing method |
0.0 |
|
108921 |
3133 |